Date published: 2025-9-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

Harmine (CAS 442-51-3)

5.0(2)
Write a reviewAsk a question

See product citations (2)

Application:
Harmine is an alkaloid of the β-carboline family that regulates PPARγ expression.
CAS Number:
442-51-3
Purity:
≥97%
Molecular Weight:
212.25
Molecular Formula:
C13H12N2O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Harmine is an alkaloid of the beta-carboline family that regulates PPARgamma expression. Harmine inhibits the Wnt signaling pathway in a cell-specific manner and down-regulates inflammatory gene expression (TNF-alpha, IL-1beta, iNOS). It reversibly inhibits MAO-A (monoamine oxidase A) but has no effect on MAO-B. Additionally, Harmine is an inhibitor of Dyrk1A, Dyrk2 and Dyrk3.


Harmine (CAS 442-51-3) References

  1. The mode of action of thiazolidinediones.  |  Hauner, H. 2002. Diabetes Metab Res Rev. 18 Suppl 2: S10-5. PMID: 11921433
  2. INTERRELATIONSHIPS BETWEEN AMPHETAMINE AND HARMALA ALKALOIDS.  |  SCHMITT, H. and SCHMITT, H. 1964. Nature. 203: 877-8. PMID: 14204082
  3. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis.  |  Chen, Q., et al. 2005. Int J Cancer. 114: 675-82. PMID: 15609303
  4. The chemotherapy of derivatives of harmine and harmaline. I.  |  Coulthard, CE., et al. 1933. Biochem J. 27: 727-39. PMID: 16745151
  5. The chemotherapy of derivatives of harmine and harmaline. II.  |  Coulthard, CE. 1934. Biochem J. 28: 264-7. PMID: 16745362
  6. The small molecule harmine is an antidiabetic cell-type-specific regulator of PPARgamma expression.  |  Waki, H., et al. 2007. Cell Metab. 5: 357-70. PMID: 17488638
  7. Novel harmine derivatives for tumor targeted therapy.  |  Li, S., et al. 2015. Oncotarget. 6: 8988-9001. PMID: 25940702
  8. Effect of Harmine and Its Derivatives Against Echinococcus granulosus and Comparison of DNA Damage Targets.  |  Gong, Y., et al. 2020. J Biomed Nanotechnol. 16: 827-841. PMID: 33187579
  9. Central inhibition prevents the in vivo acute toxicity of harmine in mice.  |  Lv, Y., et al. 2021. J Toxicol Sci. 46: 289-301. PMID: 34078836
  10. Harmine impairs memory performance of treated rats and nontreated cagemates.  |  Libânio, TC., et al. 2022. Exp Clin Psychopharmacol. 30: 751-759. PMID: 34735205
  11. Harmine-based dual inhibitors targeting histone deacetylase (HDAC) and DNA as a promising strategy for cancer therapy.  |  Lu, D., et al. 2022. Bioorg Chem. 120: 105604. PMID: 35051708
  12. Evaluation of the Effects of Harmine on β-cell Function and Proliferation in Standardized Human Islets Using 3D High-Content Confocal Imaging and Automated Analysis.  |  Title, AC., et al. 2022. Front Endocrinol (Lausanne). 13: 854094. PMID: 35860702
  13. Harmine, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium.  |  Shi, Y., et al. 2022. Front Cell Infect Microbiol. 12: 967149. PMID: 36176578
  14. Effect of moclobemide on rat brain monoamine oxidase A and B: comparison with harmaline and clorgyline.  |  Gerardy, J. 1994. Prog Neuropsychopharmacol Biol Psychiatry. 18: 793-802. PMID: 7938567
  15. Hypothermic effect of harmala alkaloid in rats: involvement of serotonergic mechanism.  |  Abdel-Fattah, AF., et al. 1995. Pharmacol Biochem Behav. 52: 421-6. PMID: 8577810

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Harmine, 250 mg

sc-202644
250 mg
$52.00

Harmine, 500 mg

sc-202644A
500 mg
$102.00

Harmine, 1 g

sc-202644B
1 g
$124.00

Harmine, 10 g

sc-202644C
10 g
$540.00

Harmine, 50 g

sc-202644D
50 g
$1438.00

Harmine, 100 g

sc-202644E
100 g
$2560.00

Harmine, 500 g

sc-202644F
500 g
$11230.00